Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments.


Journal

Fundamental & clinical pharmacology
ISSN: 1472-8206
Titre abrégé: Fundam Clin Pharmacol
Pays: England
ID NLM: 8710411

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 13 05 2020
revised: 17 06 2020
accepted: 25 06 2020
pubmed: 1 7 2020
medline: 18 9 2020
entrez: 1 7 2020
Statut: ppublish

Résumé

Patients with COVID-19 are sometimes already being treated for one or more other chronic conditions, especially if they are elderly. Introducing a treatment against COVID-19, either on an outpatient basis or during hospitalization for more severe cases, raises the question of potential drug-drug interactions. Here, we analyzed the potential or proven risk of the co-administration of drugs used for the most common chronic diseases and those currently offered as treatment or undergoing therapeutic trials for COVID-19. Practical recommendations are offered, where possible.

Identifiants

pubmed: 32603486
doi: 10.1111/fcp.12586
pmc: PMC7361515
doi:

Substances chimiques

Analgesics 0
Anti-Asthmatic Agents 0
Anti-Bacterial Agents 0
Anti-Inflammatory Agents 0
Anticoagulants 0
Antineoplastic Agents 0
Antitubercular Agents 0
Antiviral Agents 0
Cardiovascular Agents 0
Hypoglycemic Agents 0
Hypolipidemic Agents 0
Prescription Drugs 0
Psychotropic Drugs 0
Receptors, Interleukin 0
Thyroid Hormones 0
Interferon beta-1b 145155-23-3
Hydroxychloroquine 4QWG6N8QKH

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

530-547

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 Société Française de Pharmacologie et de Thérapeutique.

Références

Lancet. 2020 May 30;395(10238):1695-1704
pubmed: 32401715
Clin Pharmacol Ther. 2020 Aug;108(2):242-247
pubmed: 32246834
Clin Pharmacokinet. 2018 Oct;57(10):1347-1354
pubmed: 29453687
Ann Noninvasive Electrocardiol. 2015 Sep;20(5):426-32
pubmed: 25367596
Clin Pharmacokinet. 2002;41(14):1195-211
pubmed: 12405866
Pharmacol Res Perspect. 2017 Apr 21;5(3):e00309
pubmed: 28480041
Pharmacotherapy. 2017 Sep;37(9):1105-1121
pubmed: 28699646
Am J Transplant. 2007 Dec;7(12):2816-20
pubmed: 17949460
J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):447-54
pubmed: 22067664
J Antimicrob Chemother. 2016 Apr;71(4):1037-40
pubmed: 26747099
Br J Clin Pharmacol. 2004 Apr;57(4):436-40
pubmed: 15025741
J Addict Dis. 2005;24(1):53-60
pubmed: 15774410
Clin Pharmacol Ther. 2011 May;89(5):735-40
pubmed: 21430660
Clin Pharmacokinet. 2017 Jun;56(6):607-615
pubmed: 27722854
Crit Care Med. 2009 Mar;37(3):840-51; quiz 859
pubmed: 19237886
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Liver Int. 2020 Sep;40(9):2095-2103
pubmed: 32239796
J Clin Pharmacol. 2011 Nov;51(11):1539-48
pubmed: 21209245
Sci Transl Med. 2017 Jun 28;9(396):
pubmed: 28659436
Br J Clin Pharmacol. 1988 Sep;26(3):303-13
pubmed: 3179169
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Respir Med Case Rep. 2016 Mar 12;18:10-3
pubmed: 27144110
Curr Opin Crit Care. 2018 Jun;24(3):209-215
pubmed: 29608455
J Intern Med. 2015 Mar;277(3):277-293
pubmed: 25418337
Lancet. 2020 Feb 15;395(10223):e30-e31
pubmed: 32032529
Circulation. 2020 Jun 9;141(23):1930-1936
pubmed: 32243205
N Engl J Med. 2020 Aug 6;383(6):517-525
pubmed: 32492293
Drug Metab Dispos. 2016 Dec;44(12):1940-1948
pubmed: 27621203
Br J Clin Pharmacol. 2020 Jun;86(6):1176-1177
pubmed: 32350872
Drug Metab Dispos. 2018 Jun;46(6):835-845
pubmed: 29572333
Antivir Ther. 2014;19(4):329-39
pubmed: 24296729
Acta Psychiatr Scand. 2003 Feb;107(2):85-95
pubmed: 12534433
Acta Psychiatr Scand. 2010 May;121(5):393-7
pubmed: 19824991
Ther Drug Monit. 2005 Aug;27(4):539-43
pubmed: 16044115
Clin Pharmacokinet. 2002;41(1):19-30
pubmed: 11825095
Sci Rep. 2016 Jun 28;6:28698
pubmed: 27350308
Clin Pharmacol Ther. 2019 Jun;105(6):1345-1361
pubmed: 30916389
Transplantation. 2005 Jul 15;80(1):13-7
pubmed: 16003227
J Clin Pharmacol. 2011 Feb;51(2):237-42
pubmed: 20489027
Clin Pharmacol Ther. 2009 Apr;85(4):434-8
pubmed: 19212314
J Clin Pharmacol. 2013 Apr;53(4):444-50
pubmed: 23426978
BMJ. 2013 Jan 29;346:f288
pubmed: 23360890
Clin Pharmacokinet. 2019 Apr;58(4):503-523
pubmed: 30194612
Clin Pharmacol Ther. 2017 Mar;101(3):406-415
pubmed: 27648490
N Engl J Med. 2015 Nov 5;373(19):1886-8
pubmed: 26535533
J Thromb Thrombolysis. 2021 May;51(4):1107-1110
pubmed: 32246317
Clin Infect Dis. 2020 Sep 12;71(6):1393-1399
pubmed: 32271369
Pharmacogenet Genomics. 2018 Oct;28(10):230-237
pubmed: 30222708
Liver Transpl. 2003 Sep;9(9):954-60
pubmed: 12942457
Clin Exp Rheumatol. 1995 Jul-Aug;13(4):536
pubmed: 7586798
Clin Pharmacol Ther. 2012 Nov;92(5):584-98
pubmed: 23047648
Clin Pharmacol Ther. 2004 Jul;76(1):73-84
pubmed: 15229466
Emerg Med J. 2004 Mar;21(2):252-3
pubmed: 14988369
J Emerg Med. 2001 Nov;21(4):411-3
pubmed: 11728770
Obesity (Silver Spring). 2020 Jul;28(7):1195-1199
pubmed: 32271993
Ann Oncol. 2016 Mar;27(3):397-408
pubmed: 26681686
JAMA. 2020 May 12;323(18):1824-1836
pubmed: 32282022
Lancet Infect Dis. 2020 Sep;20(9):1012-1013
pubmed: 32251638
Bull Cancer. 2020 Jan;107(1):21-29
pubmed: 31980144
J Infect Dis. 2020 Jan 2;221(2):223-231
pubmed: 31504702
Ann Pharmacother. 2011 Jun;45(6):e34
pubmed: 21666091
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Br J Clin Pharmacol. 2011 Apr;71(4):621-3
pubmed: 21395657
Pharmacogenet Genomics. 2014 Jul;24(7):374-80
pubmed: 24849324
Ther Drug Monit. 2020 Jun;42(3):360-368
pubmed: 32304488
Curr Opin Crit Care. 2016 Feb;22(1):38-44
pubmed: 26627538
HIV Med. 2008 Jul;9(6):389-96
pubmed: 18459946
J Diabetes. 2016 May;8(3):442
pubmed: 26678559
BMJ. 1997 May 31;314(7094):1593
pubmed: 9186170

Auteurs

Florian Lemaitre (F)

Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Rennes, F-35000, France.
INSERM, Centre d'Investigation Clinique, CIC 1414, Rennes, F-35000, France.

Caroline Solas (C)

Aix-Marseille University, APHM, UMR "Emergence des Pathologies Virales" Inserm 1207 IRD 190, Laboratoire de Pharmacocinétique et Toxicologie, Hôpital La Timone, Marseille, 13005, France.

Matthieu Grégoire (M)

Clinical Pharmacology Department, CHU Nantes, Nantes Cedex 1, Nantes, 44093, France.
UMR INSERM 1235, The Enteric Nervous System in Gut and Brain Disorders, University of Nantes, Nantes Cedex 1, Nantes, 44093, France.

Laurence Lagarce (L)

Service de Pharmacologie-Toxicologie et Pharmacovigilance, Centre Hospitalo-Universitaire d'Angers, Angers, 49100, France.

Laure Elens (L)

Integrated Pharmacometrics, Pharmacogenomics and Pharmacokinetics (PMGK), Louvain Drug Research Institute (LDRI), Université Catholique de Louvain (UCL), Louvain, Belgique.
Louvain Center for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Expérimentale et Clinique (IREC), Université Catholique de Louvain (UCL), Louvain, Belgique.

Elisabeth Polard (E)

Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Rennes, F-35000, France.
INSERM, Centre d'Investigation Clinique, CIC 1414, Rennes, F-35000, France.

Béatrice Saint-Salvi (B)

Medical Interactions Unit, Agence National de Sécurité du Médicaments et des produits de santé, Saint-Denis, 93200, France.

Agnès Sommet (A)

Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, INSERM UMR 1027, CIC 1426, Toulouse University Hospital, Faculty of Medicine, University of Toulouse, Toulouse, 31000, France.

Michel Tod (M)

Pharmacy, Croix-Rousse Hospital, Lyon, 69005, France.
ISPB, University Lyon 1, Lyon, 69005, France.

Chantal Barin-Le Guellec (C)

Laboratoire de Biochimie et de Biologie Moléculaire, CHU de Tours, Tours, F37044, France.
Université de Tours, Tours, F-37044, France.
INSERM, IPPRITT, U1248, Limoges, F-87000, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH